Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders.

Molecular neurobiology - 1 Sept 2016

Wang Chong, Wang Hui-Fu, Tan Meng-Shan, Liu Ying, Jiang Teng, Zhang Dao-Qiang, Tan Lan, Yu Jin-Tai

Abstract excerpt

Rare variants of phospholipase D3 (PLD3) have been identified as Alzheimer's disease (AD) susceptibility loci, whereas little is known about the potential role of common variants in the progression of AD. To examine the impact of genetic variations in PLD3 on neuroimaging phenotypes in a large non-demented population. A total of 261 normal cognition (NC) and 456 mild cognitive impairment (MCI) individuals from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Dementia
Share to Demography

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorodeoxyglucose F18

Share to Linkage Disequilibrium

Share to Neuroimaging

Share to Phospholipase D

Share to Positron-Emission Tomography

Source

Identifiers

PMID: 26232066
DOI: 10.1007/s12035-015-9370-4

Genes

PLD3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders.PMID 26232066Read ↗

Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease.Semantic proximity Read ↗

Common Variant in PLD3 Influencing Cerebrospinal Fluid Total Tau Levels and Hippocampal Volumes in Mild Cognitive Impairment Patients from the ADNI Cohort.Semantic proximity Read ↗

PLD3 Rare Variants Identified in Late-Onset Alzheimer’s Disease Affect Amyloid-β Levels in Cellular ModelSemantic proximity Read ↗

PLD3 in Alzheimer's disease.Semantic proximity Read ↗

A variant in PPP4R3A protects against alzheimer-related metabolic decline.Semantic proximity Read ↗

PLD3 epigenetic changes in the hippocampus of Alzheimer's disease.Semantic proximity Read ↗

Genome-Wide Association Study of Brain Alzheimer's Disease-Related Metabolic Decline as Measured by [18F] FDG-PET Imaging.Semantic proximity Read ↗

PLD3 in Alzheimer's Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses.Semantic proximity Read ↗

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.Semantic proximity Read ↗

Phospholipase D3 contributes to Alzheimer’s disease risk via disruption of Aβ clearance and microglia response to amyloid plaquesSemantic proximity Read ↗

Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts.Semantic proximity Read ↗

PLD3 is a neuronal lysosomal phospholipase D associated with β-amyloid plaques and cognitive function in Alzheimer’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.